About aTyr Pharma
aTyr Pharma is a company based in San Diego (United States) founded in 2005 by Paul Schimmel and Xiang Lei Yang.. aTyr Pharma has raised $171.52 million across 9 funding rounds from investors including SVB, T. Rowe Price and SLR Investment Corp. The company has 59 employees as of December 31, 2024. aTyr Pharma operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BridgeBio, Spark Therapeutics and Revolution Medicines, among others.
- Headquarter San Diego, United States
- Employees 59 as on 31 Dec, 2024
- Founders Paul Schimmel, Xiang Lei Yang
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Atyr Pharma, Inc.
-
Annual Revenue
$235 K-33.43as on Dec 31, 2024
-
Net Profit
$-64.02 M-27.06as on Dec 31, 2024
-
EBITDA
$-66.37 M-27.21as on Dec 31, 2024
-
Total Equity Funding
$171.52 M (USD)
in 9 rounds
-
Latest Funding Round
$45.85 M (USD), Post-IPO
Aug 28, 2017
-
Investors
SVB
& 15 more
-
Employee Count
59
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of aTyr Pharma
aTyr Pharma is a publicly listed company on the NASDAQ with ticker symbol ATYR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Leadership Team
11 people
Product Management Team
5 people
Senior Team
5 people
Software Development Team
4 people
Finance and Accounting
3 people
Human Resources and Administration
2 people
Scientist Team
2 people
Legal and Compliance
1 people
Unlock access to complete
Funding Insights of aTyr Pharma
aTyr Pharma has successfully raised a total of $171.52M across 9 strategic funding rounds. The most recent funding activity was a Post-IPO round of $45.85 million completed in August 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Post-IPO — $45.8M
-
First Round
First Round
(01 Sep 2005)
- Investors Count 16
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2017 | Amount | Post-IPO - aTyr Pharma | Valuation |
investors |
|
| Nov, 2016 | Amount | Post-IPO - aTyr Pharma | Valuation |
investors |
|
| Mar, 2015 | Amount | Series E - aTyr Pharma | Valuation | Sofinnova Investments |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in aTyr Pharma
aTyr Pharma has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, T. Rowe Price and SLR Investment Corp. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private investment firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Debt and equity investments are offered by the firm.
|
Founded Year | Domain | Location | |
|
Biotech funding, drug development support, and investment in life sciences.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by aTyr Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - aTyr Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Atyr Pharma Comparisons
Competitors of aTyr Pharma
aTyr Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BridgeBio, Spark Therapeutics and Revolution Medicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Atyr Pharma
Frequently Asked Questions about aTyr Pharma
When was aTyr Pharma founded?
aTyr Pharma was founded in 2005.
Where is aTyr Pharma located?
aTyr Pharma is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of aTyr Pharma?
Sanjay S Shukla is the current CEO of aTyr Pharma.
Is aTyr Pharma a funded company?
aTyr Pharma is a funded company, having raised a total of $171.52M across 9 funding rounds to date. The company's 1st funding round was a Series E of $76.28M, raised on Sep 01, 2005.
How many employees does aTyr Pharma have?
As of Dec 31, 2024, the latest employee count at aTyr Pharma is 59.
What is the annual revenue of aTyr Pharma?
Annual revenue of aTyr Pharma is $235K as on Dec 31, 2024.
What does aTyr Pharma do?
aTyr Pharma was founded in 2005 and is headquartered in San Diego, United States. Focus is placed on the development of protein-based therapeutics targeting multiple rare diseases within the biotechnology sector. Drug candidates under advancement include ATYR2810, directed at solid tumors, and ATYR1923, intended for pulmonary sarcoidosis as well as severe respiratory complications associated with COVID-19, among others. Operations center on preclinical and clinical-stage research for these indications.
Who are the top competitors of aTyr Pharma?
aTyr Pharma's top competitors include Moderna, Jazz Pharmaceuticals and Spark Therapeutics.
Is aTyr Pharma publicly traded?
Yes, aTyr Pharma is publicly traded on NASDAQ under the ticker symbol ATYR.
Who are aTyr Pharma's investors?
aTyr Pharma has 16 investors. Key investors include SVB, T. Rowe Price, SLR Investment Corp, Viking Global Investors, and EcoR1.
What is aTyr Pharma's ticker symbol?
The ticker symbol of aTyr Pharma is ATYR on NASDAQ.